“…The results of studies on the efficacy of treatment of various types of secretory diarrhoea with somatostatin and its long-acting analogue, octreotide, have been encouraging. These drugs have been used to treat chronic diarrhoea following ileostomy (Cooper et al, 1986), the diarrhoea of tumours producing vasoactive intestinal polypeptide (Ruskone et al, 1982;Santangelo et al, 1985), carcinoid (Oberg, 1993) and medullary thyroid carcmoma (Smid and Dullaart, 1992), AIDS-related diarrhoea (Manfredi et al, 1993), short-bowel syndrome (Rosen, 1992), dumping syndrome (Lamers et al, 1993) and diabetic diarrhoea (Mourad et al, 1992;Walker and Kaplan, 1993). Octreotide has been used in these studies in doses of 50-lOO f..lg, given subcutaneously every 8-12 h.…”